Related Experiment Video
Updated: Jul 1, 2025

An Intravital Microscopy-Based Approach to Assess Intestinal Permeability and Epithelial Cell Shedding Performance
Published on: December 3, 2020
α-Ketoglutarate for Preventing and Managing Intestinal Epithelial Dysfunction
Alejandro Bravo Iniguez1, Min Du2, Mei-Jun Zhu1
1School of Food Science, Washington State University, Pullman, WA, United States.
α-Ketoglutarate (AKG) shows promise in maintaining intestinal barrier function. Supplementation may prevent gut epithelial dysfunction and support overall digestive health.
Area of Science:
- Gastroenterology and Nutritional Science
- Molecular Biology and Metabolism
Background:
- The intestinal epithelium is crucial for nutrient absorption, immune function, and barrier integrity.
- Epithelial dysfunction contributes to inflammatory bowel disease and colorectal cancer.
- Nutraceuticals are being explored to enhance intestinal epithelial homeostasis.
Purpose of the Study:
- To review the scientific literature on α-ketoglutarate (AKG) for its potential in preventing intestinal epithelial dysfunction.
- To highlight AKG's role as a metabolite with antioxidant, anti-inflammatory, and epigenetic cofactor activities.
Main Methods:
- Literature review of studies on α-ketoglutarate and intestinal health.
- Analysis of AKG's biochemical properties and known bioactivities.
- Synthesis of findings related to AKG supplementation and epithelial integrity.
Main Results:
- α-Ketoglutarate demonstrates antioxidant and anti-inflammatory properties relevant to gut health.
- AKG acts as a cofactor for epigenetic modifications, influencing gene expression.
- Evidence suggests AKG supplementation may protect against intestinal epithelial barrier disruption.
Conclusions:
- α-Ketoglutarate holds significant potential as a nutraceutical for strengthening the intestinal epithelium.
- Further research is warranted to fully elucidate AKG's therapeutic benefits for gut health and disease prevention.
More Related Videos
08:58Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
06:31Author Spotlight: Studying the Epithelial Effects of Intestinal Inflammation In Vitro on Established Murine Colonoids
Published on: June 2, 2023
Related Concept Videos
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
Acarbose and miglitol are...
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents
Adsorbents...
Drugs for Treatment of Ulcerative Colitis in IBD
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Glucose Absorption Into the Small Intestine